Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Real-world weight loss effectiveness of GLP-1 agonists among patients with type 2 diabetes: a retrospective cohort study
Clinicians should: Assess baseline HbA1c and current glycemic control before discontinuation Implement or intensify alternative therapies (metformin, SGLT2 inhibitors, or other agents) before or concurrent with tirzepatide cessation Increase home glucose monitoring frequency for several weeks post-discontinuation Schedule follow-up to evaluate metabolic stability Special consideration for insulin or sulfonylurea users : Patients taking these medications alongside tirzepatide may need proactive dose adjustments when stopping tirzepatide to prevent hypoglycemia
And ADM itself has built a supportive solutions platform for users of anti-obesity medications, leveraging its ingredient pantry and product development capabilities to offer over 25 market-ready GLP-1 complementary food and supplement concepts for its customers.
This patient-friendly infographic illustrates how GLP-1 RA-induced weight loss can be linked to nutritional deficiencies
Does GLP-1 help with belly fat
